Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis.
Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Myelin plasticity in the central nervous system.
Dentate nucleus connectivity in adult patients with multiple sclerosis: functional changes at rest and correlation with clinical features.
Glutamate signals through mGluR2 to control Schwann cell differentiation and proliferation.
Iron uptake and transport across physiological barriers.
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder.
Vascular, glial, and lymphatic immune gateways of the central nervous system.
Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.
ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility.
Suspected Acoustic Neuroma Demyelinating Lesions.
Progressive Multifocal Leucoencephalopathy and psoriasis.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells.
Automated multi-objective calibration of biological agent-based simulations.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Pages
« first
‹ previous
…
839
840
841
842
843
844
845
846
847
…
next ›
last »